文献速递哮喘慢阻肺

痰细胞计数与哮喘及慢阻肺患者卫生服务利用的关系

Sputum cellularity and health services utilization among patients with asthma and COPD.
PubMed 文献 · Chest · 2026-10-03

该回顾性队列研究纳入4821例哮喘或慢阻肺患者,将痰嗜酸粒细胞和中性粒细胞百分比与安大略省卫生行政数据库链接,分析其与住院、就诊及急诊利用的关系。结果显示哮喘患者痰嗜酸粒细胞>3%与哮喘相关卫生服务利用增加有关,而慢阻肺患者痰嗜酸粒细胞与利用无关,高痰中性粒细胞与全因住院增加有关。

要点

  • 哮喘患者痰嗜酸粒细胞>3%与哮喘相关急诊就诊率升高相关。
  • 慢阻肺患者痰嗜酸粒细胞与卫生服务利用无显著关联。
  • 慢阻肺患者高痰中性粒细胞与全因住院率升高相关。

核心结论

  • 哮喘患者痰嗜酸粒细胞>3%与哮喘相关卫生服务利用增加相关,而慢阻肺患者痰嗜酸粒细胞与卫生服务利用无关。

研究设计与样本

  • 回顾性队列研究,纳入4821例患者,其中3714例(77%)为哮喘,1107例(23%)为慢阻肺。
  • 临床数据、肺功能及痰细胞计数与安大略省卫生行政数据库(2006-2019)链接。
  • 采用负二项回归模型和广义估计方程估计相对危险度(RR)及95%置信区间(CI),调整人口学、社会经济和临床协变量。

主要发现

  • 哮喘患者中,痰嗜酸粒细胞3-15%组哮喘相关急诊就诊RR=1.92(95%CI:1.49-2.47),>15%组RR=1.88(95%CI:1.17-3.03),均高于嗜酸粒细胞<3%组。
  • 慢阻肺患者中,痰嗜酸粒细胞计数与卫生服务利用无显著关联。
  • 慢阻肺患者高痰中性粒细胞计数与全因住院增加相关(RR=1.71,95%CI:1.11-2.64)。
  • 痰嗜酸粒细胞>15%且中性粒细胞<65%的患者,哮喘相关及哮喘特异性卫生服务利用率显著更高。

临床怎么用

  • 痰嗜酸粒细胞>3%可作为哮喘患者卫生服务利用风险的标志物。
  • 慢阻肺患者应关注痰中性粒细胞升高与住院风险的关系。
  • 气道炎症表型在哮喘与慢阻肺中的临床意义存在差异。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Associations between health services utilization (HSU) and objectively measured airway inflammation in severe asthma or chronic obstructive pulmonary disease (COPD) patients remain unclear. RESEARCH QUESTION: Is there an association between quantitative sputum cell counts and HSU (hospitalizations, physician visits, emergency department visits) patterns in patients with asthma and COPD? STUDY DESIGN AND METHODS: In this retrospective cohort study, clinical data, spirometry, and sputum cell counts (% of eosinophils, neutrophils) obtained during routine clinical assessment of patients attending a university tertiary airway disease clinic were linked to Ontario health administrative databases (2006-2019). Sputum inflammatory cell counts were treated as fixed baseline exposure variables and negative binomial regression models using generalized estimating equations estimated RRs and 95% CIs for subsequent HSU adjusting for demographic, socioeconomic, and clinical covariates. RESULTS: Of the 4821 patients included, 3714(77%) had asthma only and 1107(23%) had COPD only. Among patients with asthma, sputum eosinophilia (>3%) was associated with higher asthma-specific HSU. Compared with patients with sputum eosinophils <3%, both the 3-15% and >15% eosinophil groups had similarly increased rates of asthma-specific emergency department visits (RR=1.92, 95%CI:1.49-2.47 and RR=1.88, 95%CI:1.17-3.03). Conversely, sputum eosinophil counts were not significantly associated with HSU in COPD, whereas high sputum neutrophil counts were associated with increased all-cause hospitalizations (RR=1.71, 95%CI:1.11-2.64). Overall, those with higher eosinophil (>15%) and lower neutrophil counts (<65%) had significantly higher rates of asthma-specific and asthma-related HSU. In contrast, sputum eosinophil counts were not significantly associated with increased all-cause hospitalizations among patients with COPD. INTERPRETATION: Sputum eosinophilia (>3%) is associated with increased asthma-related HSU, whereas sputum eosinophils were not associated with increased HSU in COPD. These findings support the clinical relevance of airway inflammometry in asthma and highlight important differences in inflammatory phenotypes between asthma and COPD. Further studies are needed to better understand the mechanisms underlying these associations.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Nair P, Zhang K, Lauks S, et al. Sputum cellularity and health services utilization among patients with asthma and COPD. Chest. 2026. PMID: 42829170. doi:10.1016/j.chest.2026.09.091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。